Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05157360 · ClinicalTrials.gov registry record · Phase 1
HAT for the Treatment of Sepsis Associated With NASTI
A Phase 1 study, sponsored by Ascension Health.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT05157360 is a Phase 1 study that was terminated before completion, run by Ascension Health. The registered enrollment target is 10 participants.
The verdict
NCT05157360, a Phase 1 study, was terminated before completion, sponsored by Ascension Health.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Evaluate the impact of HAT therapy versus placebo in the treatment of patients with an acute NSTI and sepsis.
Interventions
- DRUG Placebo
- DRUG HAT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-09-10 |
| Est. Completion | 2023-05-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05157360
The ClinicalTrials.gov registry entry for NCT05157360 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascension Health, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05157360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05157360 about?
NCT05157360 is a clinical study titled "HAT for the Treatment of Sepsis Associated With NASTI". Evaluate the impact of HAT therapy versus placebo in the treatment of patients with an acute NSTI and sepsis.
What is the current status of trial NCT05157360?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2021-09-10. Estimated completion is 2023-05-16.
What interventions are being tested in trial NCT05157360?
The interventions under investigation include: Placebo (DRUG), HAT (DRUG).
Who is sponsoring clinical trial NCT05157360?
This trial is sponsored by Ascension Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.